Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Aqueous suspension formulation comprising 4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluoro-phenyl)tetrahydrofuran-3-yl)methoxy)-3-methylphenyl) or a pharmaceutically acceptable salt thereof

US Patent 10513511 · Granted Dec 24, 2019

Assignee

Inventors

View full patent text on Google Patents →